• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Persistently positive SARS-CoV-2 specific IgM during one-year follow-up

tetano

tetano

Editor, Senior Moderator
J Med Virol


. 2022 May 3.
doi: 10.1002/jmv.27822. Online ahead of print.
Persistently positive SARS-CoV-2 specific IgM during one-year follow-up


Marcela Helena Gambim Fonseca[SUP] 1 [/SUP], Maria Francilene Souza Silva[SUP] 1 [/SUP], Ana Carolina Matias Dinelly Pinto[SUP] 1 [/SUP], Amanda Campelo Lima de Melo[SUP] 1 [/SUP], Fátima de Cássia Evangelista de Oliveira[SUP] 1 [/SUP], Fernanda Montenegro de Carvalho Araújo[SUP] 1 [/SUP], Luiz Odorico Monteiro de Andrade[SUP] 1 [/SUP]



Affiliations

Abstract

IgM antibodies typically appear in the early stage of infection and have a short maintenance time, so IgM is frequently used as a diagnostic criterion for acute or recent disease [1]. However, unconventional IgM specific responses have been described in SARS-COV-2 infection, raising doubts about the use of IgM as a biomarker for COVID-19 and the role of this antibody in immunity to SARS-CoV-2 [1,2]. This article is protected by copyright. All rights reserved.

Keywords: Coronavirus; Humoral immuity; Immune responses; Immunoglobin; Virus classification.
 
You must log in or register to reply here.
Back
Top Bottom